54 related articles for article (PubMed ID: 33791040)
1. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 3).
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
EFSA J; 2021 Mar; 19(3):e06554. PubMed ID: 33791038
[TBL] [Abstract][Full Text] [Related]
2. Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1).
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter J; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
EFSA J; 2021 Mar; 19(3):e06557. PubMed ID: 33791041
[TBL] [Abstract][Full Text] [Related]
3. Guidance on the preparation and submission of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 (Revision 1)
; Nutrition ; Nda A; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Salminen S; Schlatter J; Arcella D; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
EFSA J; 2021 Mar; 19(3):e06555. PubMed ID: 33791039
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis.
; Castenmiller J; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Turck D; Vinceti M; Marchelli R; van Loveren H; Dumas C; Titz A; de Henauw S
EFSA J; 2021 Jun; 19(6):e06603. PubMed ID: 34140987
[TBL] [Abstract][Full Text] [Related]
5. Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V.
; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
EFSA J; 2020 Nov; 18(11):e06304. PubMed ID: 33312234
[TBL] [Abstract][Full Text] [Related]
6. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
EFSA J; 2017 Jan; 15(1):e04680. PubMed ID: 32625270
[TBL] [Abstract][Full Text] [Related]
7. Guidance on the scientific requirements for health claims related to muscle function and physical performance: (Revision 1).
; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Thies F; Tsabouri S; Vinceti M; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Neuhäuser-Berthold M; Nowicka G; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
EFSA J; 2018 Oct; 16(10):e05434. PubMed ID: 32625715
[TBL] [Abstract][Full Text] [Related]
8. Guidance on technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles.
; More S; Bampidis V; Benford D; Bragard C; Halldorsson T; Hernández-Jerez A; Bennekou SH; Koutsoumanis K; Lambré C; Machera K; Naegeli H; Nielsen S; Schlatter J; Schrenk D; Silano Deceased V; Turck D; Younes M; Castenmiller J; Chaudhry Q; Cubadda F; Franz R; Gott D; Mast J; Mortensen A; Oomen AG; Weigel S; Barthelemy E; Rincon A; Tarazona J; Schoonjans R
EFSA J; 2021 Aug; 19(8):e06769. PubMed ID: 34377191
[TBL] [Abstract][Full Text] [Related]
9. Guidance on the assessment of exposure of operators, workers, residents and bystanders in risk assessment of plant protection products.
; Charistou A; Coja T; Craig P; Hamey P; Martin S; Sanvido O; Chiusolo A; Colas M; Istace F
EFSA J; 2022 Jan; 20(1):e07032. PubMed ID: 35079284
[TBL] [Abstract][Full Text] [Related]
10. Guidance on Communication of Uncertainty in Scientific Assessments.
; Hart A; Maxim L; Siegrist M; Von Goetz N; da Cruz C; Merten C; Mosbach-Schulz O; Lahaniatis M; Smith A; Hardy A
EFSA J; 2019 Jan; 17(1):e05520. PubMed ID: 32626067
[TBL] [Abstract][Full Text] [Related]
11. Transient Effect of Infant Formula Supplementation on the Intestinal Microbiota.
Chin N; Méndez-Lagares G; Taft DH; Laleau V; Kieu H; Narayan NR; Roberts SB; Mills DA; Hartigan-O'Connor DJ; Flaherman VJ
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33804415
[TBL] [Abstract][Full Text] [Related]
12. Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1).
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Loveren HV; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Martínez SV
EFSA J; 2021 Mar; 19(3):e06556. PubMed ID: 33791040
[TBL] [Abstract][Full Text] [Related]
13. Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates.
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Valtueña Martínez S
EFSA J; 2017 May; 15(5):e04779. PubMed ID: 32625485
[TBL] [Abstract][Full Text] [Related]
14. Scientific and technical guidance on foods for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
EFSA J; 2021 Mar; 19(3):e06544. PubMed ID: 33791036
[TBL] [Abstract][Full Text] [Related]
15. Guidance on the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof pursuant to Article 21 (2) of Regulation (EU) No 1169/2011.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
EFSA J; 2021 Mar; 19(3):e06543. PubMed ID: 33791035
[TBL] [Abstract][Full Text] [Related]
16. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
Osborn DA; Sinn J
Cochrane Database Syst Rev; 2006 Oct; (4):CD003664. PubMed ID: 17054180
[TBL] [Abstract][Full Text] [Related]
17. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
Osborn DA; Sinn J
Cochrane Database Syst Rev; 2003; (4):CD003664. PubMed ID: 14583987
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
